Clinical Trial Update: Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study [Phase 3]

View source ↗

Summary

This update notes the completion of the Dutch sub-study of the CORONA Phase 3 trial evaluating rosuvastatin in heart failure, including a PET imaging sub-study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Rosuvastatin, Heart Failure | Phase 3 | Status: COMPLETED